Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States.
Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States.
复制标题
DOI：
10.1037/pha0000572
复制
发表时间：
2023-04
影响因子：
2.3
通讯作者：
Cooper, Ziva D.
中科院分区：
文献类型：
--
作者：
Lake, Stephanie;Assaf, Ryan D.;Gorbach, Pamina M.;Cooper, Ziva D.
2019冠状病毒病（COVID-19）大流行对心理健康和物质使用产生了广泛影响。在美国，大麻的使用有所增加，但人们对大麻使用者使用其他物质的变化知之甚少。我们试图研究COVID-19期间酒精，烟草，阿片类药物和兴奋剂使用的变化，并探索这些变化与大麻使用模式的关系。数据来自于2020年9月对美国使用大麻的成年人（n = 1，471）进行的网络调查。使用回顾性（大流行前）和调查时间评估期间报告的数据，我们探讨了使用医用和非医用大麻的受访者在COVID-19期间定期（≥每周）饮酒，吸烟，阿片类药物和兴奋剂使用的流行率变化。我们使用修改后的泊松回归来研究大麻相关的相关性增加或减少在大流行期间的第二种物质的使用。仅在医疗使用组中，≥每周一次饮酒的情况略有但显著增加（41.4%-47.0%，p = 0.034）。≥每周烟草、阿片类药物和兴奋剂的使用没有显著变化。大流行同时发生的次要药物使用的变化取决于相互作用的大麻相关因素，包括医用大麻使用、大流行前大麻使用频率和大流行同时发生的频率变化。例如，仅在医用大麻使用组中，大流行前大麻使用≥每周一次与阿片类药物使用频率下降显著正相关。评估大流行对物质使用的影响时，应考虑大麻与其他物质之间的关系，这种关系可能因大麻特定的行为、动机和使用背景而异。
The coronavirus disease 2019 (COVID-19) pandemic has had widespread impacts on mental health and substance use. Increases in cannabis use have been documented in the United States, but little is known about how other substance use has changed among people who use cannabis. We sought to examine changes in alcohol, tobacco, opioid, and stimulant use during COVID-19 and explore how these changes relate to patterns of cannabis use. Data were obtained from a web-based survey of adults in the United States who use cannabis (n = 1,471) administered in September 2020. Using data reported in retrospective (prepandemic) and time-of-survey assessment periods, we explored changes in the prevalence of regular (≥ weekly) alcohol, tobacco, opioid, and stimulant use during COVID-19 among respondents who used medical and nonmedical cannabis. We used modified Poisson regression to examine cannabis-related correlates of increasing or decreasing secondary substance use during the pandemic. There was a slight but significant increase in ≥weekly alcohol use in the medical use group only (41.4%–47.0%, p = .034). ≥Weekly tobacco, opioid, and stimulant use did not change significantly. Pandemic-concurrent shifts in secondary substance use depended on interacting cannabis-related factors including medical cannabis use, prepandemic cannabis frequency, and pandemic-concurrent frequency changes. For example, ≥weekly prepandemic cannabis use was significantly and positively associated with decreasing opioid use frequency among the medical cannabis use group only. Assessments of the pandemic’s effects on substance use should consider relationships between cannabis and other substances, which may differ according to cannabis-specific behaviors, motives, and contexts of use.
登录
查看更多内容
影响因子：
4.4
作者：
Blevins CE;Abrantes AM;Anderson BJ;Caviness CM;Herman DS;Stein MD
通讯作者：
Stein MD
影响因子：
2.8
作者：
Horigian, Viviana E.;Schmidt, Renae D.;Feaster, Daniel J.
通讯作者：
Feaster, Daniel J.
影响因子：
4.7
作者：
Benschop A;van Bakkum F;Noijen J
通讯作者：
Noijen J
影响因子：
4.7
作者：
McPhee MD;Keough MT;Rundle S;Heath LM;Wardell JD;Hendershot CS
通讯作者：
Hendershot CS
影响因子：
2.7
作者：
Assaf, Ryan D.;Gorbach, Pamina M.;Cooper, Ziva D.
通讯作者：
Cooper, Ziva D.